stars 1 stars 2 stars 3

Amytrx Therapeutics is advancing a new class of peptide therapies to overcome inflammatory diseases—with a vision of providing transformative medicines to patients. Drawing on 25 years of research, Amytrx is harnessing the power of novel anti-inflammatory peptide discoveries to advance new medicines aimed at the prevention and treatment of inflammatory diseases. Our lead therapeutic candidate, AMTX-100, is bioengineered from human protein sequences that modulate the immune system by a natural process, reducing pathogenesis in a range of chronic diseases mediated by excessive inflammation. Joining forces with institutions for clinical research, Amytrx Therapeutics is dedicated to transforming the conventional treatment of chronic inflammatory diseases using biological technology that is easily understood by the human body in a way that is safe, effective, and simple to use.

View Top Employees from Amytrx Therapeutics, Inc.

Amytrx Therapeutics, Inc. Questions

Danny Helton is the Vice President Chemistry and Manufacturing of Amytrx Therapeutics, Inc..

3 people are employed at Amytrx Therapeutics, Inc..

Amytrx Therapeutics, Inc. is based in Nashville, Tennessee.

The NAICS codes for Amytrx Therapeutics, Inc. are [3254, 32541, 325, 541, 32, 54].

The SIC codes for Amytrx Therapeutics, Inc. are [283, 87, 873, 28].

Top Amytrx Therapeutics, Inc. Employees

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users